Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Mission Wealth Management LP

Mission Wealth Management LP lessened its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 4.4% during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 31,819 shares of the medical equipment provider's stock after selling 1,452 shares during the quarter. Mission Wealth Management LP's holdings in Intuitive Surgical were worth $15,759,000 as of its most recent filing with the SEC.

Other hedge funds have also made changes to their positions in the company. Castleark Management LLC increased its stake in shares of Intuitive Surgical by 3.4% during the fourth quarter. Castleark Management LLC now owns 90,469 shares of the medical equipment provider's stock worth $47,221,000 after buying an additional 2,990 shares during the period. Truist Financial Corp increased its stake in shares of Intuitive Surgical by 3.0% during the fourth quarter. Truist Financial Corp now owns 248,092 shares of the medical equipment provider's stock worth $129,494,000 after buying an additional 7,298 shares during the period. FourThought Financial Partners LLC purchased a new stake in shares of Intuitive Surgical during the fourth quarter worth approximately $1,158,000. Longbow Finance SA purchased a new stake in shares of Intuitive Surgical during the fourth quarter worth approximately $4,431,000. Finally, Blue Trust Inc. increased its stake in shares of Intuitive Surgical by 19.7% during the fourth quarter. Blue Trust Inc. now owns 4,467 shares of the medical equipment provider's stock worth $2,332,000 after buying an additional 734 shares during the period. Institutional investors and hedge funds own 83.64% of the company's stock.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, SVP Mark Brosius sold 216 shares of the firm's stock in a transaction on Friday, June 6th. The stock was sold at an average price of $563.11, for a total value of $121,631.76. Following the completion of the sale, the senior vice president now owns 907 shares of the company's stock, valued at approximately $510,740.77. This trade represents a 19.23% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Jami K. Nachtsheim sold 2,400 shares of the firm's stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $520.00, for a total value of $1,248,000.00. Following the completion of the sale, the director now directly owns 6,371 shares of the company's stock, valued at approximately $3,312,920. This trade represents a 27.36% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 4,998 shares of company stock valued at $2,611,577. 0.70% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Several brokerages have commented on ISRG. Evercore ISI dropped their price target on shares of Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating on the stock in a research note on Wednesday, April 23rd. Erste Group Bank upgraded shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a research note on Thursday, June 5th. Truist Financial dropped their price target on shares of Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating on the stock in a research note on Wednesday, April 23rd. BTIG Research set a $560.00 price target on shares of Intuitive Surgical and gave the company a "buy" rating in a research note on Monday, April 14th. Finally, Citigroup reiterated a "buy" rating and issued a $650.00 price target (up from $590.00) on shares of Intuitive Surgical in a research note on Thursday, May 22nd. One analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have given a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $588.95.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG opened at $512.18 on Monday. The stock has a fifty day moving average price of $526.57 and a 200 day moving average price of $538.46. Intuitive Surgical, Inc. has a 1-year low of $413.82 and a 1-year high of $616.00. The company has a market cap of $183.57 billion, a PE ratio of 79.90, a P/E/G ratio of 5.85 and a beta of 1.67.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, topping the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The firm had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.19 billion. During the same period last year, the company earned $1.50 earnings per share. Analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.